Cargando…
Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
BACKGROUND/OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy associated with high metastatic risk. Prognosis remains poor even after resection. Previously our group identified biomarkers that improved diagnostic accuracy in PDAC beyond the established diagnostic tumour...
Autores principales: | Kruger, Deirdré, Lahoud, Nicola, Yako, Yandiswa Y., Devar, John, Smith, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8754286/ https://www.ncbi.nlm.nih.gov/pubmed/35020761 http://dx.doi.org/10.1371/journal.pone.0262439 |
Ejemplares similares
-
Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy
por: Kruger, Deirdré, et al.
Publicado: (2019) -
Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Yako, Yandiswa Yolanda, et al.
Publicado: (2016) -
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023) -
Serum Metabolomic and Lipoprotein Profiling of Pancreatic Ductal Adenocarcinoma Patients of African Ancestry
por: Elebo, Nnenna, et al.
Publicado: (2021) -
Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
por: Xiao, Yuanyuan, et al.
Publicado: (2017)